International Flavors & Fragrances Inc (IFF) shareholders
Close on Nov 13, 2026Market cap $20.71BP/E –Yield 1.97%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dodge & Cox | 35,047,387 | 13.70% | 13G (passive) amendment | Jun 30, 2025 |
| Haldor Foundation Joint filing with Winder Pte. Ltd. (9.90%), Winder Investment Anstalt (9.90%) and 2 more | 25,356,381 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Vanguard Capital Management | 18,842,232 | 7.37% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 17,980,322 | 7.00% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IFF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dodge & Cox | 37,007,037 | 14.50% | $2.93B | +534,095 | 1.53% |
| Freemont Capital Pte Ltd | 25,356,381 | 9.94% | $2.01B | – | 40.99% |
| BlackRock, Inc. | 23,175,401 | 9.08% | $1.84B | +454,108 | 0.03% |
| First Eagle Investment Management, LLC | 18,819,396 | 7.38% | $1.49B | +9,504,726 | 1.24% |
| Vanguard Capital Management LLC | 16,255,207 | 6.37% | $1.29B | +16,982 | 0.03% |
| State Street Corp | 12,340,998 | 4.84% | $982.39M | +1,053,044 | 0.03% |
| Vanguard Portfolio Management LLC | 11,608,686 | 4.55% | $919.64M | −114,545 | 0.04% |
| Invesco Ltd. | 9,403,330 | 3.69% | $744.93M | +1,910,489 | 0.06% |
| Geode Capital Management, LLC | 6,812,731 | 2.67% | $537.58M | −144,460 | 0.03% |
| UBS Asset Management Americas Inc | 6,112,514 | 2.40% | $484.23M | −94,581 | 0.09% |
| First Pacific Advisors, LP | 5,455,081 | 2.14% | $432.15M | +45,156 | 5.34% |
| Icahn Carl C | 4,275,000 | 1.68% | $338.67M | – | 4.10% |
| Massachusetts Financial Services Co /Ma/ | 3,871,551 | 1.52% | $331.69M | +804,612 | 0.11% |
| State Farm Mutual Automobile Insurance Co | 3,821,419 | 1.50% | $302.73M | – | 0.21% |
| Eurizon Capital SGR S.p.A. | 3,226,394 | 1.26% | $254.34M | +1,081,714 | 0.68% |
| Ameriprise Financial Inc | 2,967,609 | 1.16% | $235.11M | +283,515 | 0.05% |
| Northern Trust Corp | 2,932,363 | 1.15% | $232.30M | +18,464 | 0.03% |
| Nykredit A/S | 2,815,771 | 1.10% | $223.07M | New | 0.70% |
| Continental Grain Co | 2,682,730 | 1.05% | $212.53M | +260,000 | 47.41% |
| Morgan Stanley | 2,678,783 | 1.05% | $212.21M | +101,055 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 751 | 282M | 100.0% | 112 / 295 | 230 / 56 | 36M | 11M |
| Q1 2026 | 704 | 257M | 100.0% | 91 / 283 | 203 / 81 | 45M | 14M |
| Q4 2025 | 708 | 256M | 100.0% | 120 / 235 | 237 / 100 | 30M | 17M |
| Q3 2025 | 705 | 244M | 95.5% | 103 / 250 | 252 / 82 | 26M | 24M |
| Q2 2025 | 689 | 242M | 94.7% | 83 / 258 | 245 / 103 | 20M | 17M |
| Q1 2025 | 718 | 239M | 93.6% | 76 / 253 | 265 / 103 | 16M | 14M |
| Q4 2024 | 759 | 238M | 93.3% | 96 / 229 | 318 / 112 | 43M | 37M |
| Q3 2024 | 787 | 232M | 91.0% | 89 / 290 | 275 / 67 | 34M | 16M |
| Q2 2024 | 770 | 236M | 92.5% | 100 / 246 | 294 / 60 | 17M | 23M |
| Q1 2024 | 740 | 243M | 95.2% | 88 / 250 | 280 / 105 | 33M | 28M |
| Q4 2023 | 764 | 238M | 93.1% | 119 / 228 | 305 / 86 | 29M | 27M |
| Q3 2023 | 740 | 236M | 92.6% | 101 / 278 | 246 / 113 | 52M | 20M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
614 funds held IFF in Q2 2026, 38% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IFF | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 17,514,000 | 6.86% | $1.39B | 1.17% | Jun 30, 2026 |
| Dodge & Cox International Stock Fund | 7,740,800 | 3.03% | $613.23M | 0.91% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 7,700,590 | 3.02% | $610.04M | 0.03% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 6,615,642 | 2.59% | $524.09M | 0.03% | Jun 30, 2026 |
| First Eagle Global Fund | 6,578,172 | 2.58% | $521.12M | 0.69% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 3,511,244 | 1.38% | $278.16M | 0.03% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 3,277,275 | 1.28% | $249.24M | 0.03% | May 31, 2026 |
| FPA Crescent Fund | 3,163,067 | 1.24% | $250.58M | 2.01% | Jun 30, 2026 |
| State Street(R) Materials Select Sector SPDR(R) ETF | 2,789,986 | 1.09% | $221.02M | 2.71% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,781,911 | 1.09% | $220.38M | 0.12% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 2,628,001 | 1.03% | $208.19M | 0.09% | Jun 30, 2026 |
| Washington Mutual Investors Fund | 2,550,137 | 1.00% | $202.02M | 0.09% | Jul 31, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,510,449 | 0.98% | $198.88M | 0.21% | Jul 31, 2026 |
| Dodge & Cox Global Stock Fund | 2,447,927 | 0.96% | $193.92M | 1.49% | Jun 30, 2026 |
| Invesco Comstock Fund | 2,304,949 | 0.90% | $182.60M | 1.22% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| J. Erik Fyrwald | Chief Executive Officer, Director | 120,966 | 0.05% | Nov 3, 2026 |
| de Mendonca Ana Paula Teles | President, Scent | 0 | – | Aug 19, 2026 |
| Marc Birenkrant | Controller & CAO | 9,643 | 0.00% | Aug 10, 2026 |
| Michael DeVeau | EVP, CFO | 5,199 | 0.00% | Aug 7, 2026 |
| Ralf Finzel | EVP, Global Operations Officer | 17,621 | 0.01% | May 6, 2026 |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 37,925 | 0.01% | May 6, 2026 |
| Yuvraj Arora | President, Taste & CCO | 17,283 | 0.01% | May 4, 2026 |
| Andres Roberto Muller | President, Food Ingredients | 3,016 | 0.00% | Apr 3, 2026 |
| Stephen N. Landsman | EVP, General Counsel | 17,164 | 0.01% | Apr 3, 2026 |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 5,983 | 0.00% | Apr 3, 2026 |
| Beril Yildiz | CAO, SVP & Controller | 3,321 | 0.00% | May 19, 2025 |
| Angela Strzelecki | President, Pharma Solutions | 10,362 | 0.00% | Apr 7, 2025 |
| Jennifer Amy Johnson | EVP, General Counsel | 7,357 | 0.00% | Mar 6, 2025 |
| Simon Herriott | Pres. Health & Bioscience | 10,755 | 0.00% | Mar 6, 2025 |
| Mehmood Khan | Director | 7,173 | 0.00% | Nov 4, 2026 |
| Paul J. Fribourg | Director | 2,726,339 | 1.07% | Jun 2, 2026 |
| Dawn C. Willoughby | Director | 434 | 0.00% | May 5, 2026 |
| Cynthia T. Jamison | Director | 604 | 0.00% | May 5, 2026 |
| Jesus B. Mantas | Director | – | – | May 5, 2026 |
| Richard Mulligan | Director | 1,712 | 0.00% | May 4, 2026 |
| Kevin O'Byrne | Director | 26,071 | 0.01% | May 4, 2026 |
| Virginia Drosos | Director | 2,434 | 0.00% | May 4, 2026 |
| Brett Icahn | Director | 34,712 | 0.01% | May 4, 2026 |
| Mark J. Costa | Director | 463 | 0.00% | Mar 25, 2026 |
| Hernandez Margarita Palau | Director | 2,393 | 0.00% | May 20, 2025 |
| Vincent J. Intrieri | Director | 604 | 0.00% | May 5, 2025 |
| Kathryn Jean Boor | Director | 255 | 0.00% | May 5, 2025 |
| John Francis Ferraro | Director | – | – | May 5, 2025 |
| Pte. Ltd. Winder | 10% owner | 25,356,381 | 9.94% | Nov 12, 2026 |
| Investment Anstalt Winder | 10% owner | – | – | Nov 12, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| de Mendonca Ana Paula Teles President, Scent | Aug 17, 2026 | Sale | −5,718 | $83.19 | $475.68K | 0 |
| Marc Birenkrant Controller & CAO | Aug 7, 2026 | Sale | −1,000 | $85.00 | $85.00K | 3,446 |
| Michael DeVeau EVP, CFO | Aug 6, 2026 | Sale | −8,825 | $85.55 | $754.98K | 5,199 |
| Paul J. Fribourg Director | Jun 1, 2026 | Buy | +260,000 | $74.28 | $19.31M | 2,682,730 |
| Paul J. Fribourg Director | Jun 1, 2026 | Buy | +13,500 | $74.49 | $1.01M | 43,150 |
| Marc Birenkrant Controller & CAO | May 4, 2026 | Tax withholding | −141 | $70.09 | $9.88K | 4,446 |
| Marc Birenkrant Controller & CAO | May 4, 2026 | Option exercise | +389 | – | – | 4,587 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 4, 2026 | Tax withholding | −713 | $70.09 | $49.97K | 37,925 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 4, 2026 | Option exercise | +1,768 | – | – | 38,638 |
| Michael DeVeau EVP, CFO | May 4, 2026 | Tax withholding | −452 | $70.09 | $31.68K | 14,024 |
| Michael DeVeau EVP, CFO | May 4, 2026 | Option exercise | +884 | – | – | 14,476 |
| Ralf Finzel EVP, Global Operations Officer | May 4, 2026 | Tax withholding | −734 | $70.09 | $51.45K | 17,621 |
| Ralf Finzel EVP, Global Operations Officer | May 4, 2026 | Option exercise | +1,326 | – | – | 18,355 |
| de Mendonca Ana Paula Teles President, Scent | May 4, 2026 | Tax withholding | −362 | $70.09 | $25.37K | 5,718 |
| de Mendonca Ana Paula Teles President, Scent | May 4, 2026 | Option exercise | +708 | – | – | 6,080 |
| Mehmood Khan Director | May 1, 2026 | Option exercise | +2,569 | – | – | 7,173 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 1, 2026 | Option exercise | +2,381 | – | – | 37,830 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 1, 2026 | Tax withholding | −960 | $70.81 | $67.98K | 36,870 |
| Richard Mulligan Director | May 1, 2026 | Option exercise | +1,712 | – | – | 1,712 |
| Kevin O'Byrne Director | May 1, 2026 | Tax withholding | −1,157 | $70.81 | $81.93K | 17,571 |
| Kevin O'Byrne Director | May 1, 2026 | Option exercise | +4,282 | – | – | 18,728 |
| Virginia Drosos Director | May 1, 2026 | Option exercise | +2,335 | – | – | 2,434 |
| de Mendonca Ana Paula Teles President, Scent | May 1, 2026 | Tax withholding | −625 | $70.81 | $44.26K | 5,372 |
| de Mendonca Ana Paula Teles President, Scent | May 1, 2026 | Option exercise | +1,587 | – | – | 5,997 |
| Yuvraj Arora President, Taste & CCO | May 1, 2026 | Tax withholding | −1,828 | $70.81 | $129.44K | 17,283 |
| Yuvraj Arora President, Taste & CCO | May 1, 2026 | Option exercise | +3,572 | – | – | 19,111 |
| Brett Icahn Director | May 1, 2026 | Option exercise | +1,712 | – | – | 34,712 |
| Michael DeVeau EVP, CFO | May 1, 2026 | Tax withholding | −710 | $70.81 | $50.28K | 13,592 |
| Michael DeVeau EVP, CFO | May 1, 2026 | Option exercise | +1,389 | – | – | 14,302 |
| Ralf Finzel EVP, Global Operations Officer | May 1, 2026 | Option exercise | +1,984 | – | – | 18,127 |
| Ralf Finzel EVP, Global Operations Officer | May 1, 2026 | Tax withholding | −1,098 | $70.81 | $77.75K | 17,029 |
| J. Erik Fyrwald Chief Executive Officer, Director | May 1, 2026 | Tax withholding | −7,763 | $70.81 | $549.70K | 109,676 |
| J. Erik Fyrwald Chief Executive Officer, Director | May 1, 2026 | Option exercise | +15,875 | – | – | 117,439 |
| Marc Birenkrant Controller & CAO | May 1, 2026 | Tax withholding | −144 | $70.81 | $10.20K | 4,198 |
| Marc Birenkrant Controller & CAO | May 1, 2026 | Option exercise | +397 | – | – | 4,342 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Tax withholding | −1,335 | $72.57 | $96.88K | 5,983 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Option exercise | +4,305 | – | – | 4,305 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Option exercise | +3,013 | – | – | 7,318 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Tax withholding | −1,908 | $72.57 | $138.46K | 4,075 |
| Ralf Finzel EVP, Global Operations Officer | Apr 1, 2026 | Tax withholding | −868 | $72.57 | $62.99K | 16,143 |
| Ralf Finzel EVP, Global Operations Officer | Apr 1, 2026 | Option exercise | +2,152 | – | – | 17,011 |
| de Mendonca Ana Paula Teles President, Scent | Apr 1, 2026 | Tax withholding | −932 | $72.57 | $67.64K | 4,410 |
| de Mendonca Ana Paula Teles President, Scent | Apr 1, 2026 | Option exercise | +2,583 | – | – | 5,342 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | Apr 1, 2026 | Option exercise | +2,030 | – | – | 36,268 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | Apr 1, 2026 | Tax withholding | −819 | $72.57 | $59.43K | 35,449 |
| Marc Birenkrant Controller & CAO | Apr 1, 2026 | Tax withholding | −171 | $72.57 | $12.41K | 3,945 |
| Marc Birenkrant Controller & CAO | Apr 1, 2026 | Option exercise | +473 | – | – | 4,116 |
| Yuvraj Arora President, Taste & CCO | Apr 1, 2026 | Option exercise | +4,305 | – | – | 17,742 |
| Yuvraj Arora President, Taste & CCO | Apr 1, 2026 | Tax withholding | −2,203 | $72.57 | $159.87K | 15,539 |
| Michael DeVeau EVP, CFO | Apr 1, 2026 | Tax withholding | −2,418 | $72.57 | $175.47K | 12,913 |
| Michael DeVeau EVP, CFO | Apr 1, 2026 | Option exercise | +4,735 | – | – | 15,331 |
| Andres Roberto Muller President, Food Ingredients | Apr 1, 2026 | Tax withholding | −759 | $72.57 | $55.08K | 3,016 |
| Andres Roberto Muller President, Food Ingredients | Apr 1, 2026 | Option exercise | +2,583 | – | – | 3,775 |
| Stephen N. Landsman EVP, General Counsel | Apr 1, 2026 | Tax withholding | −1,164 | $72.57 | $84.47K | 17,164 |
| Stephen N. Landsman EVP, General Counsel | Apr 1, 2026 | Option exercise | +3,228 | – | – | 18,328 |
| J. Erik Fyrwald Chief Executive Officer, Director | Apr 1, 2026 | Option exercise | +18,769 | – | – | 110,399 |
| J. Erik Fyrwald Chief Executive Officer, Director | Apr 1, 2026 | Tax withholding | −8,835 | $72.57 | $641.16K | 101,564 |
| J. Erik Fyrwald Chief Executive Officer, Director | Mar 13, 2026 | Buy | +13,360 | $69.85 | $933.20K | 91,630 |
| Paul J. Fribourg Director | Mar 12, 2026 | Buy | +14,200 | $70.07 | $994.99K | 29,650 |
| Paul J. Fribourg Director | Mar 12, 2026 | Buy | +142,000 | $70.13 | $9.96M | 2,422,730 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of International Flavors & Fragrances's stock actually held short. Settlement fails (shares not delivered on time) peaked at 75,662 shares on Sep 18, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| de Mendonca Ana Paula Teles Officer | Aug 17, 2026 | 5,718 | $475.69K | Aug 17, 2026 | Restricted Stock Vesting |
| Marc Birenkrant Officer | Aug 7, 2026 | 1,000 | $85.00K | Aug 7, 2026 | Restricted Stock Vesting |
| Michael DeVeau Officer | Aug 6, 2026 | 8,825 | $754.97K | Aug 6, 2026 | Restricted Stock Vesting |
| Beril Yildiz Former Officer | Nov 7, 2025 | 4,060 | $253.81K | Nov 7, 2025 | Restricted Stock Vesting |
| Beril Yildiz Officer | May 19, 2025 | 2,400 | $185.60K | May 19, 2025 | Restricted Stock Vesting |
| Yuvraj Arora Officer | Nov 12, 2024 | 5,000 | $458.78K | Nov 11, 2024 | Restricted Stock Vesting |
| Angela Strzelecki Officer | Jun 13, 2024 | 2,588 | $247.56K | Jun 13, 2024 | Option Granted - 02/19/2020 |
| Fauchon de Villeplee Christophe Officer | May 11, 2023 | 1,972 | $170.28K | May 11, 2023 | Restricted Stock Units |
See a number that looks wrong?